Elif Demirdogen

CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer.

Nuran Bayram, B. Tunca, U. Egeli, 2012, Tumori.

CK19, CK20, EGFR and HER2 Status of Circulating Tumor Cells in Patients with Breast Cancer

Nuran Bayram, B. Tunca, U. Egeli, 2012 .

Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.

B. Tunca, U. Egeli, G. Cecener, 2014, Asian Pacific journal of cancer prevention : APJCP.

Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.

U. Topal, B. Tunca, U. Egeli, 2016, Asian Pacific journal of cancer prevention : APJCP.

BRCA1/2 Germline Mutations and Their Clinical Importance in Turkish Breast Cancer Patients

Nuran Bayram, B. Tunca, U. Egeli, 2014, Cancer investigation.

Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson’s patients and genotype-phenotype correlations

Esen Saka, O. Doğu, B. Elibol, 2016, Clinical Neurology and Neurosurgery.

Ocular response analyzer to assess corneal biomechanical properties in exfoliation syndrome and exfoliative glaucoma

P. Yılmazbaş, A. Cankaya, Elif Demirdogen, 2012, Graefe's Archive for Clinical and Experimental Ophthalmology.

Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.

Maristela L Onozato, A. Iafrate, M. Onozato, 2017, Cancer discovery.